Royal Bank Of Canada Soma Logic, Inc. Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.76 - $2.83 $24,632 - $39,608	13,996 Added 52.18%	40,818 $103,000
Q3 2023 Nov 14, 2023	BUY	$1.99 - $2.45 $6,081 - $7,487	3,056 Added 12.86%	26,822 $64,000
Q2 2023 Aug 14, 2023	BUY	$2.1 - $3.36 $28,440 - $45,504	13,543 Added 132.48%	23,766 $54,000
Q1 2023 May 15, 2023	SELL	$2.13 - $3.6 $44,329 - $74,923	-20,812 Reduced 67.06%	10,223 $26,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $3.47 $20,227 - $34,238	9,867 Added 46.61%	31,035 $77,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $1,643 - $14,271	2,609 Added 14.06%	21,168 $61,000
Q2 2022 Aug 15, 2022	SELL	$4.27 - $8.26 $20,666 - $39,978	-4,840 Reduced 20.68%	18,559 $85,000
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $38,665 - $63,549	5,469 Added 30.5%	23,399 $188,000
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $2,674 - $3,641	255 Added 1.44%	17,930 $208,000
Q3 2021 Nov 15, 2021	BUY	$9.94 - $12.77 $175,689 - $225,709	17,675 New	17,675 $219,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.